Literature DB >> 28249254

Evaluation of the Impact of a New Synthetic Vitamin E-Bonded Membrane on the Hypo-Responsiveness to the Erythropoietin Therapy in Hemodialysis Patients: A Multicenter Study.

Francesco Locatelli1, Simeone Andrulli, Sara Maria Viganò, Massimo Concetti, Sauro Urbini, Franca Giacchino, Roberto Broccoli, Filippo Aucella, Maria Cossu, Paolo Conti, Laura Fattori, Giorgio Punzo, Daniela Angelini, Marco Peruzzini, Salvatore Di Giulio, Marta Piroddi, Francesco Galli, Lucia Del Vecchio.   

Abstract

BACKGROUND: Oxidative stress has been related to hypo-response to erythropoiesis-stimulating agents (ESAs) in hemodialysis (HD) patients. The aim of this study was to verify whether vitamin E (ViE) on a synthetic polysulfone dialyzer can improve ESA responsiveness.
METHODS: This controlled, multicenter study involved 93 HD patients on stable ESA therapy, who were randomized to either ViE-coated polysulfone dialyzer or to a low-flux synthetic dialyzer. The primary outcome measure was the change in ESA resistance index (ERI) from baseline.
RESULTS: Mean ERI decreased in the ViE group by 1.45 IU/kg*g/dl and increased in the control group by 0.53 IU/kg*g/dl, with a mean difference of 1.98 IU/kg*g/dl (p = 0.001 after adjusting for baseline ERI, as foreseen by the study protocol). Baseline ERI was inversely related to its changes during follow-up only in the control group (R2 = 0.29).
CONCLUSIONS: The ViE dialyzer can improve ESA response in HD patients. Changes in ERI during follow-up are independent from baseline ERI only in the ViE group. Video Journal Club 'Cappuccino with Claudio Ronco' at http://www.karger.com/?doi=453442.
© 2017 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28249254     DOI: 10.1159/000453442

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  7 in total

Review 1.  Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease.

Authors:  Henry H L Wu; Rajkumar Chinnadurai
Journal:  Kidney Dis (Basel)       Date:  2022-01-14

Review 2.  Vitamin E (Alpha-Tocopherol) Metabolism and Nutrition in Chronic Kidney Disease.

Authors:  Francesco Galli; Mario Bonomini; Desirée Bartolini; Linda Zatini; Gianpaolo Reboldi; Giada Marcantonini; Giorgio Gentile; Vittorio Sirolli; Natalia Di Pietro
Journal:  Antioxidants (Basel)       Date:  2022-05-18

3.  Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial.

Authors:  Terumasa Hayashi; Shoichi Maruyama; Masaomi Nangaku; Ichiei Narita; Hideki Hirakata; Kenichiro Tanabe; Satoshi Morita; Yoshiharu Tsubakihara; Enyu Imai; Tadao Akizawa
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-03       Impact factor: 8.237

4.  Vitamin E-Bonded Membranes Do Not Influence Markers of Oxidative Stress in Hemodialysis Patients with Homozygous Glutathione Transferase M1 Gene Deletion.

Authors:  Petar Djuric; Sonja Suvakov; Tatjana Simic; Dragana Markovic; Djurdja Jerotic; Aleksandar Jankovic; Ana Bulatovic; Jelena Tosic Dragovic; Tatjana Damjanovic; Jelena Marinkovic; Radomir Naumovic; Nada Dimkovic
Journal:  Toxins (Basel)       Date:  2020-05-27       Impact factor: 4.546

5.  Clinical evaluation of performance, biocompatibility, and safety of vitamin E-bonded polysulfone membrane hemodialyzer compared to non-vitamin E-bonded hemodialyzer.

Authors:  Mercedeh Kiaii; Masaharu Aritomi; Mitsuyo Nagase; Myriam Farah; Beverly Jung
Journal:  J Artif Organs       Date:  2019-06-26       Impact factor: 1.731

Review 6.  Influence of Dialysis Membranes on Clinical Outcomes: From History to Innovation.

Authors:  Yee-An Chen; Shuo-Ming Ou; Chih-Ching Lin
Journal:  Membranes (Basel)       Date:  2022-01-26

Review 7.  Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy.

Authors:  Mario Bonomini; Luca Piscitani; Lorenzo Di Liberato; Vittorio Sirolli
Journal:  Biomedicines       Date:  2022-04-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.